Healthcare -
Biotechnology - NASDAQ - US
$ 21.98
-1.7 %
$ 16.2 B
Market Cap
-95.57
P/E
SMMT - TOTAL RECEIVABLES
Total Receivables SMMT - Summit Therapeutics Inc.
848 K
LAST VALUE
-23.89%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR